The decision memorandum Resolution of Semaglutide Injection Product Shortage and Supply Status, dated February 21, 2025, sets forth the FDAs full legal analysis upon which the February Declaratory Order is based.[ix] The FDA acknowledged that it has received reports that some patients and pharmacists are not able to obtain the semaglutide injection products through the normal supply chain
People with multiple NAION risk factors such as sleep apnoea, high blood pressure and diabetes should undergo careful consideration with their treating doctor before starting these medications
Neither the drug label for injectable Ozempic nor for the recently announced Ozempic pill has a drug interaction warning for any antidepressant medication, which means theyre likely safe to take together, but as well see below, there still may be some things to watch out for
Brooks JO 3rd, Yesavage JA, Carta A, Bravi D
Those who are overweight or have type 2 diabetes are known to be at a greater risk of NAION in general, but the current analysis found a key difference in this risk factor when patients were treated with semaglutide